M. Islam, M. Rupeshkumar, and K. B. Reddy, “Streptozotocin is more convenient than Alloxan for the induction of Type 2 diabetes”, Int J of Pharmc Res, vol. 7, no. 1, pp. 06–11, Feb. 2017, doi: 10.7439/ijpr.v7i1.3818.